Biofrontier Partners

Biofrontier Partners

United States; California United States; Chuo City Tokyo Japan; Asia; East Asia; Americas; North America; Northwest
Is it you?
Investor info
Type
Venture Capital
Sweet spot
$20,250,000
Stage focus
  • Seed Round,
  • Early stage VC,
  • Later stage VC
Geography focus
Australia, Canada, Europe, Japan, United States
Industry focus
Description
Biofrontier Partners is a Japan-based venture capital and investment firm focused on life sciences, biotechnology, and healthcare innovation. The firm primarily invests in early-stage companies developing pharmaceuticals, drug discovery platforms, medical technologies, and advanced biomedical research applications. It often works closely with universities, research institutions, and corporate R&D groups to support the commercialization of scientific discoveries. Biofrontier Partners typically participates in seed and early growth rounds, providing both funding and strategic guidance to help companies navigate clinical and regulatory development pathways. Its investment strategy is centered on deep-tech life science innovation within the Japanese and broader Asian biotech ecosystem.
Previous investments
  • Company
    Amount
    Round
  • Example example company Inc
    1000000
    Investor meetings
  • Company & Company
    11000000
    Series C funding
  • Example
    524000
    Seed round A
Show more
Connected people
Email visible after logging in
  • Example Example
    Example Exampleexample[email protected]
  • Example Exampleexample
    Example Exampleexample
  • Notexample Examplenot
    Notexample Examplenotexample example[email protected]
  • Example Examplenotexample
    Example Examplenotexampleexample example[email protected]
  • Example Example
    Example Exampleexample[email protected]
  • Example Example
    Example Exampleexample[email protected]
Show more
See other investors focused on
Life Sciences
Other investors you may be interested in
Made with in San Francisco, Berlin, Valencia, Oslo, Cherkasy and Warsaw© 2015-     Foundersuite, Inc.